Wealth Management Associates, Inc. Bridge Bio Pharma, Inc. Transaction History
Wealth Management Associates, Inc.
- $257 Billion
- Q2 2025
A detailed history of Wealth Management Associates, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Wealth Management Associates, Inc. holds 8,500 shares of BBIO stock, worth $475,660. This represents 0.14% of its overall portfolio holdings.
Number of Shares
8,500
Previous 8,980
5.35%
Holding current value
$475,660
Previous $310 Million
18.23%
% of portfolio
0.14%
Previous 0.13%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
409Shares Held
187MCall Options Held
11.3MPut Options Held
2.2M-
Viking Global Investors LP18.6MShares$1.04 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$922 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$742 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$697 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$519 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $8.3B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...